Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(3-Chlorophenyl)-1-hydroxy-2-propanone is an organic compound that serves as an intermediate in the synthesis of bupropion hydrochloride, a medication used to treat depression and help individuals quit smoking. It is also known as Bupropion USP Related Compound F.

857233-13-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 857233-13-7 Structure
  • Basic information

    1. Product Name: 1-(3-Chlorophenyl)-1-hydroxy-2-propanone
    2. Synonyms: 1-(3-Chlorophenyl)-1-hydroxy-2-propanone;Bupropion Hydrochloride Related Compound F (30 mg) (1-(3-chlorophenyl)-1-hydroxy-2-propanone) (COLD SHIPMENT REQUIRED);1-(M-Chlorophenyl)-1-hydroxy-2-propanone;Buprion Related CoMpound F;Bupropion IMpurity-F(USP);Bupropion USP Related CoMpound F;Bupropion Related CoMpound F;1-(3-chlorophenyl)-1-hydroxypropan-2-one
    3. CAS NO:857233-13-7
    4. Molecular Formula: C9H9ClO2
    5. Molecular Weight: 184.61956
    6. EINECS: N/A
    7. Product Categories: Aromatics;Intermediates;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 857233-13-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 106-108 °C(Press: 0.5 Torr)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.240 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: Hygroscopic, -86°C Freezer, Under inert atmosphere
    8. Solubility: Chloroform (Slightly), DMSO (Slightly), Ethanol (Slightly), Ethyl Acetate (Slig
    9. PKA: 12.06±0.20(Predicted)
    10. Stability: Hygroscopic, Temperature Sensitive, Unstable in Solution
    11. CAS DataBase Reference: 1-(3-Chlorophenyl)-1-hydroxy-2-propanone(CAS DataBase Reference)
    12. NIST Chemistry Reference: 1-(3-Chlorophenyl)-1-hydroxy-2-propanone(857233-13-7)
    13. EPA Substance Registry System: 1-(3-Chlorophenyl)-1-hydroxy-2-propanone(857233-13-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 857233-13-7(Hazardous Substances Data)

857233-13-7 Usage

Uses

Used in Pharmaceutical Industry:
1-(3-Chlorophenyl)-1-hydroxy-2-propanone is used as a bupropion intermediate for the synthesis of bupropion hydrochloride, a medication that aids in treating depression and smoking cessation. Its role in the production process is crucial for creating the final drug product.

Check Digit Verification of cas no

The CAS Registry Mumber 857233-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,7,2,3 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 857233-13:
(8*8)+(7*5)+(6*7)+(5*2)+(4*3)+(3*3)+(2*1)+(1*3)=177
177 % 10 = 7
So 857233-13-7 is a valid CAS Registry Number.

857233-13-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1078799)  Bupropion Hydrochloride Related Compound F  United States Pharmacopeia (USP) Reference Standard

  • 857233-13-7

  • 1078799-40MG

  • 15,782.13CNY

  • Detail

857233-13-7Downstream Products

857233-13-7Relevant articles and documents

Kinetic study and peak purity determination of bupropion hydrochloride using RRLC/DAD and HPLC/MWD methods: Stability study and application in pharmaceutical preparation and in synthetic mixtures with nicotine

El-Kosasy, Amira M.,Hussein, Lobna A.,Salama, Nahla N.,Sedki, Nehal G.

, p. 64274 - 64285 (2015/08/18)

Two simple, specific, and precise stability indicating chromatographic methods have been developed, optimized, and validated for the purity determination of bupropion HCl (BUP) in bulk powders, pharmaceutical preparations as well as in the presence of its hydrolytic and oxidative degradation products and its co-administered drug nicotine (NIC). The first method was based on the determination of the cited drug using High Performance Liquid Chromatography (HPLC). The adequate separation of BUP from its degradation products and NIC was obtained using an Intertsil ODS3 (250 x 4.6 mm i.d., 5 μm particle size) column. The method was used to investigate the kinetics of the alkaline and oxidative degradation processes of BUP where the order rate constants, half lives, and activation energies were calculated. The second method was based on using Rapid Resolution Liquid Chromatography (RRLC) to separate BUP from its degradation products on a XDB C18 (50 x 4.6 mm i.d., 1.8 μm particle size) column. The linear ranges were 5-100 and 2-20 μg mL-1 with LOD of 1.33 and 0.2 μg mL-1 for the HPLC and RRLC methods, respectively. The quantification in both methods was based on coupling the separation with dual wavelength detection at 250 nm for BUP and NIC and at 224 nm for the degradation products. The peak purity of BUP in its pharmaceutical preparation spiked with its degradates revealed symmetry factors (999.935 & 999.963) within the calculated thresholds (>999.841 & >999.901) for HPLC and RRLC, respectively. The suggested methods were validated in compliance with the ICH and USP guidelines. The assay methods were successfully used to estimate BUP in Wellbutrin 150 SR tablets and good percentage recoveries were obtained. The developed methods were statistically compared with the official USP methods and compared favourably with no significant difference in terms of accuracy and precision.

Hyphenating the curtius rearrangement with morita-baylis-hillman adducts: Synthesis of biologically active acyloins and vicinal aminoalcohols

Amarante, Giovanni W.,Cavallaro, Mayra,Coelho, Fernando

, p. 1568 - 1584 (2011/11/06)

Using Morita-Baylis-Hillman adducts as substrates, the Curtius rearrangement was performed in a sequence that allowed the synthesis of several hydroxy-ketones (acyloins) with great structural diversity and in good overall yields. These acyloins in turn were easily transformed into 1,2-anti aminoalcohols through a highly diastereoselective reductive amination step. The synthetic utility of these approaches was exemplified by performing the syntheses of (±)-bupropion, a drug used to treat the abstinence syndrome of smoker and (±)-spisulosine, a potent anti-tumoral compound originally isolated form a marine source.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 857233-13-7